Untreated OSA fragments sleep and may promote intermittent hypoxemia and inflammation, which can interact with aspiration risk and respiratory infection vulnerability in susceptible patients.
Effective PAP therapy targets airway patency during sleep; clinicians should also address reflux, dental and swallow concerns, and vaccination status as part of holistic respiratory risk reduction.
This article is educational and not a substitute for individualized medical advice.